Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melphalan Dose Comparison with Amifostine in Multiple Myeloma
NCT00217438Phase 3Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jul 2005
- Primary completion
- Oct 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of melphalan in multiple myeloma (MM), sponsored by Fred Hutchinson Cancer Center. Started Jul 2005; status: completed.
02
Drugs
melphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00217438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00217438.